Research Progress of Spironolactone as an Antagonist of NRG1-ERBB4 Pathway in the Treatment of Cognitive Impairment in Schizophrenia
Low Birth Weight and Its Association with Pattern and Risk of Acute Respiratory Infection Among Infants in Rivers State, Nigeria: What Can we do to Improving the Situation?